Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease

Renal Failure

Volumn 26, Issue 6, 2004, Pages 715-725

  Krause, Michelle W ^a,b,f   Massing, Mark ^b,c   Kshirsagar, Abhijit ^d   Rosamond, Wayne ^c   Simpson Jr , Ross J ^b,c,e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Medical Review of North Carolina   (United States)

^c IL   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f Division of Nephrology   (United States)

Author keywords

Cardioprotective medication use; Cardiovascular disease; Chronic kidney disease

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; GLOMERULUS FILTRATION RATE; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICARE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL RATE;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CARDIOTONIC AGENTS; COHORT STUDIES; CONFIDENCE INTERVALS; DRUG THERAPY, COMBINATION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; REGISTRIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 9644268103     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200037110     Document Type: Article

References (45)

1. Rosamond, W.D.; Chambless, L.E.; Folsom, A.R.; Lawton, C.S.; Conwill, D.E.; Clegg, L.; Wang, C.H.; Heiss, G. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N. Engl. J. Med. 1998, 339, 861-868.
2. Gu, K.; Cowie, C.C.; Harris, M.I. Diabetes and decline in heart disease mortality in U.S. adults. JAMA 1999, 281, 1291-1297.
3. The Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection and Treatment of High Blood Pressure. Arch. Intern. Med. 1997, 157, 2413-2446.
4. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1998, 2, 349-360.
5. Antiplatelet Trialists Collaboration. Collaborative overview of randomized trial of antiplatelet therapy. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994, 308, 81.
6. Beta Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction: mortality results. JAMA 1982, 247, 1707-1714.
7. Yusuf, S.; Lessem, J.; Jha, P. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated controlled trials. J. Hypertens. 1993, 11, S61-S73.
8. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med. 1981, 304, 801-807.
9. Teo, K.K.; Yusuf, S.; Furberg, C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993, 270, 1589-1595.
10. ISIS-4 Collaborative Group. ISIS-4. a randomized factorial trial assessing early captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995, 345, 669-685.
11. K/DOQI Advisory Board Members. Clinical practice guidelines for chronic kidney disease. Part 4. Definition and classification of stages of chronic kidney disease. Am. J. Kidney Dis. 2002, 39, S46-S75.
12. United States Renal Data System. USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States; National Institutes of Health, National Institute of Diabetes, Digestive, Kidney Diseases: Bethesda, MD, 2001.
13. Rostand, S.; Kirk, K.; Rutsky, E. Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int. 1982, 6, 304-308.
14. Foley, R.N.; Parfrey, P.S.; Harnett, J.D.; Kent, G.M.; Martin, C.J.; Murray, D.C.; Barre, P.E. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995, 47, 186-192.
15. Appel, G. Lipid abnormalities in renal disease. Kidney Int. 1991, 39, 169-183.
16. Bostom, A.G.; Shemin, D.; Lapane, K.L. Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study. Atherosclerosis 1996, 125, 91-101.
17. Goodman, W.G.; Goldin, J.; Kuizon, B.D. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 2000, 342, 1478-1483.
18. ACC/AHA Guidelines for the Management of Patients with Acute Myocardial Infarction 1999. Updated Guideline; http://www.americanheart. org/Scientific/statements/1999/AMI (accessed 2000 Jul 23).
19. Ellerbeck, E.F.; Jencks, S.F.; Radford, M.J.; Ellerbeck, E.F.; Jencks, S.F.; Radford, M.J.; Kresowik, T.F.; Craig, A.S.; Gold, J.A.; Krumholz, H.M.; Vogel, R.A. Quality care for medicare patients with acute myocardial infarction: a four state pilot study from the cooperative cardiovascular project. JAMA 1995, 273, 1509-1514.
20. Krumholz, H.M.; Chen, J.; Wang, Y.; Radford, M.J.; Chen, Y.T.; Marciniak, T.A. Comparing AMI mortality among hospitals in patients 65 years of age and older. Circulation 1999, 99, 2986-2992.
21. International Classification of Diseases, Clinical Modification, 9th Ed.; Public Health Service, US Department of Health and Human Services: Washington, DC, 1998.
22. Levey, A.S.; Greene, T.; Kusek, J.W.; Beck, G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. J. Am. Soc. Nephrol. 2000, 11, 828A.
23. Maschio, G.; Alberti, D.; Janin, G.; Locatelli, F.; Mann, J.; Ponticelli, C.; Ritz, E.; Zucchelli, P. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N. Engl. J. Med. 1996, 334, 939-945.
24. Massie, B.M.; Armstrong, P.W.; Cleland, J.G.; Horowitz, J.D.; Packer, M.; Poole-Wilson, P.A.; Ryden, L. Toleration of high doses of angiotensin- converting enzyme inhibitors in patients with chronic heart failure. Arch. Intern. Med. 2001, 161, 165-171.
25. Ahuja, T.S.; Freeman, D.; Mahnken, J.D.; Agraharkar, M.; Siddiqui, M.; Memon, A. Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors. Am. J. Nephrol. 2000, 20, 268-272.
26. Reardon, L.C.; MacPherson, D.S. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch. Intern. Med. 1998, 158, 26-32.
27. Durand, D.; Ader, S.L.; Rey, J.P.; Tran-Van, P.; Lloveras, J.J.; Bernadet, P.; Sue, J.M. Inducing hyperkalemia by converting enzyme inhibitors and heparin. Kidney Int. 1988, 25, S196-S197.
28. Jolobe, D.M. Nephrotoxicity in the elderly due to the co-prescription of ace inhibitors and NSAIDS. J. Royal Soc. Med. 2001, 94, 657-658.
29. Knight, E.L.; Glynn, R.J.; McIntyre, K.M.; Mogun, H.; Avorn, J. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy. Am. Heart J. 1999, 5, 849-855.
30. Bakris, G.L.; Weir, M.R. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch. Intern. Med. 2000, 160, 685-693.
31. Frances, C.D.; Noguchi, H.; Massie, B.M.; Browner, W.S.; McClelland, M. Are we inhibited? Renal insufficiency should not preclude the use of ace inhibitors for patients with myocardial infarction and depressed left ventricular function. Arch. Intern. Med. 2000, 160, 2645-2650.
32. Jafar, T.H.; Schmidt, C.H.; Landa, M.; Giatras, I.; Toto, R.; Remuzzi, G.; Maschio, G.; Brenner, B.M.; Kamper, A.; Levey, A.S. Angiotensin-converting enzyme inhibitors and the progression of nondiabetic renal disease. A meta-analysis of patient level data. Ann. Intern. Med. 2001, 135, 73-87.
33. Lewis, E.J.; Hunsicker, L.G.; Bain, R.P.; Rohde, R.D. The effect of angiotensin converting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N. Engl. J. Med. 1993, 329, 1456-1462.
34. Livio, M.; Benigini, A.; Vigano, G.; Mecca, G.; Remuzzi, G. Moderate doses of aspirin and the risk of bleeding in renal failure. Lancet 1986, 1, 414-416.
35. Remuzzi, G.; Mingardi, G.; Mecca, G.; Donati, M.D.; de Gaetano, G. Does aspirin precipitate major gastro-intestinal bleeding in patients on hemodialysis? Lancet 1977, 2, 359-360.
36. Herzog, C.A.; Ma, J.Z.; Collins, A.J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N. Engl. J. Med. 1998, 12, 799-805.
37. Herzog, C.A.; Ma, J.Z.; Collins, A.J. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am. J. Kidney Dis. 2000, 36, 145-152.
38. Chertow, G.M.; Normand, S.L.; Silva, L.R.; McNeill, B.J. Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. Am. J. Kidney Dis. 2000, 35, 1044-1051.
39. Herzog, C.A. Acute myocardial infarction in patients with end stage renal disease. Kidney Int. 1999, 56, S130-S133.
40. Daumit, G.L.; Hermann, J.A.; Coresh, J.; Coresh, J.; Powe, N.R. Use of cardiovascular procedures among black persons and white persons: a 7-year nationwide study in patients with renal disease. Ann. Intern. Med. 1999, 130, 173-182.
41. Nissenson, A.R.; Collins, A.J.; Hurley, J.; Peterson, H.; Pereira, B.J.; Steinberg, E.P. Opportunity for improving the care of patients with chronic renal insufficiency: current practice patterns. J. Am. Soc. Nephrol. 2001, 12, 1713-1720.
42. Johnston, S.C. Identifying confounding by indication through blinded prospective review. Am. J. Epidemiol. 2001, 154, 276-284.
43. Smith, S.C.; Gilpin, E.; Ahnve, S. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. J. Am. Coll. Cardiol. 1991, 16, 784-792.
44. Normand, S.L.; Glickman, M.E.; Sharma, R.G.; McNeil, B.J. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: results from the cooperative cardiovascular project. JAMA 1996, 275, 1322-1329.
45. K/DOQI Advisory Board Members. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002, 39, S1-S266.